Divi's Laboratories Ltd. (DIVI)

Currency in INR
6,569.00
-10.00(-0.15%)
Real-time Data·
Advertisement
DIVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,530.506,665.50
52 wk Range
5,636.507,071.50
Key Statistics
Bid/Ask
6,569.00 / 6,570.00
Prev. Close
6,579
Open
6,599
Day's Range
6,530.5-6,665.5
52 wk Range
5,636.5-7,071.5
Volume
105.33K
Average Volume (3m)
345.33K
1-Year Change
-4.1931%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7,059.47
Upside
+7.47%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Divi's Laboratories Ltd. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

15 Buy
6 Hold
9 Sell
Ratings:
30 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 7,059.47
(+7.47% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Macquarie
Buy7,500.00+14.17%-Maintain26/05/2026
Goldman Sachs
Buy8,035.00+22.32%-Upgrade25/05/2026
ICICI Securities
Sell6,150.00-6.38%5,900.00Maintain25/05/2026
JPMorgan
Buy7,400.00+12.65%7,300.00Maintain25/05/2026
HSBC
Hold6,900.00+5.04%-Downgrade25/05/2026

Earnings

Latest Release
22/05/2026
EPS / Forecast
28.31 / 26.04
Revenue / Forecast
28.31B / 28.51B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 96.75%
Dividend Yield
0.46%
Industry Median 0.70%
Annualised payout
30.00
Paid annually
5-Years Growth
+8.45%
Growth Streak

Compare DIVI to Peers and Sector

Metrics to compare
DIVI
Peers
Sector
Relationship
P/E Ratio
68.2x40.9x−0.4x
PEG Ratio
3.95−0.030.00
Price/Book
10.5x3.5x2.6x
Price / LTM Sales
16.6x3.9x3.0x
Upside (Analyst Target)
6.1%5.6%53.6%
Fair Value Upside
Unlock−1.4%7.6%Unlock

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Employees
10542
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
62.52M23.55%410.00B
Other Institutional Investors
22.33M8.41%146.41B
Public Companies & Retail Investors
180.62M68.04%1.18T
Total
265.47M100.00%1.74T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SBI Funds Management Limited4.56%12,102,44579,361,783
Singapore3.55%9,416,09261,746,023

People Also Watch

1,444.10
NEST
+2.77%
7,126.00
EICH
+0.74%
417.70
BHEL
+0.87%
415.75
BAJE
+0.96%
1,587.80
PIDI
-0.31%

FAQ

What Is the Divi's Labs (NSE: DIVI) Share Price Today?

The Divi's Labs stock price today is 6,569.00 INR.

What Stock Exchange Does Divi's Labs (DIVI) Trade On?

Divi's Labs is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Divi's Labs?

The stock symbol (also called a 'ticker') for Divi's Labs is "DIVI."

Does Divi's Labs Pay Dividends? What’s The Current DIVI Dividend Yield?

Yes, DIVI Pays Dividends to its Shareholders. The current Divi's Labs dividend yield is 0.46%.

What Is the Current Divi's Labs Market Capitalisation?

As of today, Divi's Labs (NSE: DIVI) market cap is 1.74T INR.

What Is Divi's Labs's (DIVI) Earnings Per Share (TTM)?

The Divi's Labs EPS is currently 96.75 (Trailing Twelve Months).

When Is the Next Divi's Labs Earnings Date?

Divi's Labs's next earnings report will be released on 07/08/2026.

Is DIVI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Divi's Labs moving averages and other technical indicators, the daily buy/sell signal for DIVI stock is Strong Sell.

How Many Times Has Divi's Labs Stock Split?

Divi's Labs has split 3 times. (See the DIVI stock split history page for full effective split date and price information.)

How Many Employees Does Divi's Labs Have?

Divi's Labs has 10542 employees, based on their latest Companies House report.

What is the current trading status of Divi's Labs (NSE: DIVI)?

As of 01/07/2026, Divi's Labs (DIVI) is trading at a share price of 6,569.00 INR, with a previous close of 6,579.00 INR. The stock has fluctuated within a day range of 6,530.50 INR to 6,665.50 INR, while its 52-week range spans from 5,636.50 INR to 7,071.50 INR.

What Is Divi's Labs (DIVI) Price Target According to Analysts?

The average 12-month price target for Divi's Labs is 7,059.47 INR, with a high estimate of 9450 INR and a low estimate of 5160 INR. 15 analysts recommend buying the stock, while 9 suggest selling, leading to an overall rating of Neutral. The stock has an +7.47% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.